Home › Companies › Y-mAbs Therapeutics, Inc.
How asset managers voted at Y-mAbs Therapeutics, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | Y-mAbs Therapeutics, Inc. | 3 | 126 |
| 2023-2024 | Y-MABS THERAPEUTICS INC. | 5 | 137 |
Earlier seasons list this company under the name Y-MABS THERAPEUTICS INC., as its holders filed it.
Explore Y-mAbs Therapeutics, Inc. in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built October 13, 2026.